Skip to main content
. Author manuscript; available in PMC: 2021 May 27.
Published in final edited form as: ACS Appl Mater Interfaces. 2020 May 12;12(21):23752–23763. doi: 10.1021/acsami.0c05311

Figure 5.

Figure 5.

(A) Cell viability of DPSCs within the bioprinted constructs using ECM and AMP-modified bioinks is consistently above 90% for at least 5 days. (B–E) Osteogenic differentiation shows enhanced DPSCs’ differentiation into functional osteoblasts capable of secreting a mineralized matrix. (B) ALP assay, (C) ARS assay, and (D,E) osteogenic gene expression at day 14 and 21 (*p < 0.05).